Researchers from 15 countries, led by Amsterdam UMC, have developed a way to predict which patients are at risk of epilepsy after a cerebral venous sinus thrombosis (CVT).
WEHI spinout aims to revolutionize the development of cancer drugs
Australia has cemented its role in becoming a major player in the next generation of medicines with the launch of Ternarx – a globally competitive